---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-052452"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2025-05-23T23:59:59+00:00"
generated_at: "2026-05-20T14:29:56.956863+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics raises $13M in public offering of common stock and warrants

## Summary
- Offering of 9,285,714 shares and warrants to purchase 18,571,428 shares at combined price $1.40 per unit.
- Gross proceeds of ~$13M; closing expected May 27, 2025.
- Warrants exercisable immediately at $1.40/share, expire in 5 years, with beneficial ownership cap.
- GMS Ventures (affiliated with directors) committed $6M of the offering.
- Underwriting agreement entered with BTIG, LLC.

## SEC filing metadata
- accession: 0001104659-25-052452
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2025-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465925052452/0001104659-25-052452-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465925052452/tm2516054d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-052452
- JSON: https://secwatch.observer/filing/0001104659-25-052452.json
- Plain text: https://secwatch.observer/filing/0001104659-25-052452.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.